Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,787Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M196EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)21.2Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.1PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M24,950,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IBB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
IBBGeorge Soros 2016-03-31 Buy 0.49%$244.04 - $338.33
$ 272.041%New holding67,600
IBBJohn Keeley 2015-09-30 Sold Out -0.01%$289.48 - $398
$ 272.04-24%Sold Out0
IBBGeorge Soros 2015-09-30 Sold Out -0.01%$289.48 - $398
$ 272.04-24%Sold Out0
IBBGeorge Soros 2015-06-30 Buy 0.01%$333.61 - $383.19
$ 272.04-24%New holding2,400
IBBJohn Keeley 2014-12-31 Buy 0.01%$255.27 - $308.01
$ 272.04-4%New holding905
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IBB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

IBB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Atkinson, Richard Collier10% Security Holder 2016-05-06Buy169,000$0.08339950view
Reeson, DouglasDirector, Senior Officer 2016-05-06Buy100,000$0.03906700view
Crossett, Paul Everett10% Security Holder 2016-05-06Buy61,000$15575.51view
Bal, Jatinder SinghIssuer 2016-05-06Sell20,000$0.06453300view
Bowerman, GordonDirector 2016-05-05Buy5,000$1.0725324.3view
Yamini, BahmanDirector, Senior Officer 2016-05-03Buy5,000$0.23118178.26view
Buskard, James LivingstoneSenior Officer 2016-05-02Sell50,000$0.5549361.82view
Bal, Jatinder SinghDirector 2016-05-02Sell125,000$0.1271940view
Bal, Jatinder SinghIssuer 2016-05-02Sell30,000$0.05543980view
Dubuc, PhilippeSenior Officer 2016-04-08Buy1,700$1.9913570.35view

Press Releases about IBB :

Quarterly/Annual Reports about IBB:

    News about IBB:

    Articles On GuruFocus.com
    Brandes Funds Comments on Publicis May 24 2016 
    Brandes Funds Comments on Credit Suisse May 24 2016 
    Brandes Funds Comments on Barclays May 24 2016 
    Brandes International Equity Fund Q1 Commentary May 24 2016 
    Brandes Funds Comments on Embraer May 24 2016 
    Spirit Airlines' Selloff Is Unjustified May 24 2016 
    Starbucks Is Still Overvalued May 24 2016 
    The Investors’ Dilemma: Why 2016 May Be a Turning Point - Brandes Investment Funds May 24 2016 
    Mobileye Is a Good Company, But the Stock's Valuation Is Insane May 24 2016 
    JetBlue's Underserving Selloff Is a Buying Opportunity May 24 2016 

    More From Other Websites
    Incyte Guidance on Jakafi Sends Stock High May 24 2016
    Xenoport Surges on Takeover Bid and Outperforms the Market May 24 2016
    Rlypsa Stock Pops on New Data and a Huge Risk May 23 2016
    Stocks End Week On High Note; Chips, Biotechs Power Nasdaq May 20 2016
    IBB Mid-Cap News: Pfizer Acquired Anacor for $5.2 Billion May 18 2016
    Nasdaq dips into correction May 17 2016
    Busting Another Election Year ETF Myth May 17 2016
    Agilent Technologies Topped the Large Caps Last Week May 17 2016
    Stock market bulls want to see breakouts here, quickly! May 17 2016
    What Lies Ahead for Biotech ETFs? May 13 2016
    Fear trades: Copper, biotech & shorting tech May 13 2016
    Nasdaq, S&P dragged lower by Apple; Dow industrials end in the green May 12 2016
    Analyzing Medivation’s Growth Opportunity with Xtandi May 12 2016
    Biotech, China, Japan ETFs among 2016 Laggards: ETF.com May 11 2016
    Wednesday links: a lack of confidence May 11 2016
    Actinium Pharmaceuticals Remains Significantly Undervalued May 10 2016
    The small cap squeeze: When more money chases fewer companies May 10 2016
    S&P, Nasdaq eke out gains as health-care stocks rise; Dow sunk by oil slump May 09 2016
    Charts See Possible Value in Apple, Facebook May 08 2016
    Startling Disclosure in Relypsa's Filings Reveal a Possible Sanofi Takeover May 08 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)